U.S. Biohacking Market Size & Outlook, 2026-2033
- Biotechnology
- Bioprocessing
- Biohacking Market Outlook
- Bioprocessing
Global Market
Related Markets
Ask Prism AI anything about the biohacking market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
U.S. biohacking market highlights
- The U.S. biohacking market generated a revenue of USD 7,680.4 million in 2025 and is expected to reach USD 33,205.6 million by 2033.
- The U.S. market is expected to grow at a CAGR of 20.4% from 2026 to 2033.
- In terms of segment, wearables was the largest revenue generating product in 2025.
- Smart Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
Biohacking market data book summary
| Market revenue in 2025 | USD 7,680.4 million |
| Market revenue in 2033 | USD 33,205.6 million |
| Growth rate | 20.4% (CAGR from 2026 to 2033) |
| Largest segment | Wearables |
| Fastest growing segment | Smart Drugs |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gene Modification Kits, Supplements, Mobile Apps, Implants (Chips), Smart Drugs, Wearables |
| Key market players worldwide | Apple Inc, Fitbit, Harvey Norman Holdings Ltd, The ODIN, Thync, Moodmetric, Thriveport, TrackMyStack, OsteoStrong San Jose |
Other key industry trends
- In terms of revenue, U.S. accounted for 26.5% of the global biohacking market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. biohacking market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 33,205.6 million by 2033.
The U.S. dominates the global biohacking market, driven by a strong biotech ecosystem, high consumer awareness, and significant R&D investments. The country has a thriving community of biohackers, ranging from DIY enthusiasts to advanced research institutions collaborating on cutting-edge technologies like gene editing, bioelectronic implants, and AI-driven health monitoring.
The increasing focus on longevity, cognitive enhancement, and performance optimization is fueling the adoption of biohacking solutions. Additionally, partnerships between biotech firms, pharmaceutical companies, and digital health startups are accelerating innovation in biohacking industry.
No credit card required*
Publish Date: Jun 29, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biohacking Market Scope
Biohacking Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Apple Inc | View profile | 161,000 | One Apple Park Way, Cupertino, CA, United States, 95014 | www.apple.com |
| Fitbit | View profile | 251-500 | San Francisco, California, United States, North America | www.fitbit.com |
| Harvey Norman Holdings Ltd | View profile | 6,500 | A1 Richmond Road, Homebush West, Sydney, NSW, Australia, 2140 | www.harveynormanholdings.com.au |
| The ODIN | View profile | 1-10 | Oakland, California, United States, North America | the-odin.com/ |
| Thync | View profile | 1-10 | Menlo Park, California, United States, North America | www.thync.com/ |
| Moodmetric | View profile | 1-10 | Kouvola, Southern Finland, Finland, Europe | www.moodmetric.com |
| Thriveport | View profile | 11-50 | Los Angeles, California, United States, North America | www.thriveport.com |
| TrackMyStack | View profile | 1-10 | Toronto, Ontario, Canada, North America | trackmystack.com |
| OsteoStrong San Jose | View profile | - | San Jose, California, United States, North America | osteostrongsanjose.com/ |
U.S. Biohacking Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biohacking Market Outlook will help companies and investors design strategic landscapes.
Wearables was the largest segment with a revenue share of 35.18% in 2025.
Horizon Databook has segmented the U.S. biohacking market based on gene modification kits, supplements, mobile apps, implants (chips), smart drugs, wearables covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. dominates the global biohacking market, driven by a strong biotech ecosystem, high consumer awareness, and significant R&D investments. The country has a thriving community of biohackers, ranging from DIY enthusiasts to advanced research institutions collaborating on cutting-edge technologies like gene editing, bioelectronic implants, and AI-driven health monitoring.
The increasing focus on longevity, cognitive enhancement, and performance optimization is fueling the adoption of biohacking solutions. Additionally, partnerships between biotech firms, pharmaceutical companies, and digital health startups are accelerating innovation in biohacking industry.
- U.S. Biohacking Market Product Outlook (Revenue, USD Million , 2021-2033)
- Wearables
- Implants (Chips)
- Gene Modification Kits
- Smart Drugs
- Supplements
- Mobile Apps
- Others
- U.S. Biohacking Market Application Outlook (Revenue, USD Million , 2021-2033)
- Synthetic Biology
- Genetic Engineering
- Forensic Science
- Drug Testing
- Diagnosis & Treatment
- U.S. Biohacking Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
- Forensic Laboratories
- Research & Academic Institutes
- Others
Reasons to subscribe to Biohacking Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biohacking Market Outlook databook
- Our clientele includes a mix of Biohacking Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Biohacking Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Biohacking Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Biohacking Market, 2021-2033 (US$M)
US Product - Biohacking Market Statistics, 2025 - 2033 (US$M)
